Clover Health Investments (CLOV) Misses Q1 EPS by 2c ; Offers Guidance

Clover Health Investments (NASDAQ: CLOV) reported Q1 EPS of $0.05, $0.02 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $749.2 million versus the consensus estimate of $714.89 million.

GUIDANCE:

Clover Health Investments sees FY2026 revenue of $2.81-2.92 billion, versus the consensus of $2.88 billion.

For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• BuzzFeed sells shares to Byron Allen affiliate for $5.8 million
• ZenaTech raises Plurilock Security stake to 12% with new share purchase